135 related articles for article (PubMed ID: 11836342)
1. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.
Zapata PD; Ropero RM; Valencia AM; Buscail L; López JI; Martín-Orozco RM; Prieto JC; Angulo J; Susini C; López-Ruiz P; Colás B
J Clin Endocrinol Metab; 2002 Feb; 87(2):915-26. PubMed ID: 11836342
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
[TBL] [Abstract][Full Text] [Related]
3. SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma.
Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; degli Uberti EC
Endocrinology; 2005 Jun; 146(6):2692-8. PubMed ID: 15746253
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
[TBL] [Abstract][Full Text] [Related]
5. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
Qu CK; Feng GS
Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
8. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
9. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
Benali N; Cordelier P; Calise D; Pages P; Rochaix P; Nagy A; Esteve JP; Pour PM; Schally AV; Vaysse N; Susini C; Buscail L
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9180-5. PubMed ID: 10900262
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
12. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
[TBL] [Abstract][Full Text] [Related]
13. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
14. Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS
Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
[TBL] [Abstract][Full Text] [Related]
15. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
16. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
[TBL] [Abstract][Full Text] [Related]
17. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
18. [Phosphotyrosine phosphatase SHP-1, somatostatin and prostate cancer].
Zapata PD; Colas B; López-Ruiz P; Ropero RM; Martín RM; Rodríguez FJ; González FJ; López JI; Angulo JC
Actas Urol Esp; 2004 Apr; 28(4):269-85. PubMed ID: 15248398
[TBL] [Abstract][Full Text] [Related]
19. Regulation of acidification and apoptosis by SHP-1 and Bcl-2.
Thangaraju M; Sharma K; Leber B; Andrews DW; Shen SH; Srikant CB
J Biol Chem; 1999 Oct; 274(41):29549-57. PubMed ID: 10506221
[TBL] [Abstract][Full Text] [Related]
20. Perinuclear localization of the protein-tyrosine phosphatase SHP-1 and inhibition of epidermal growth factor-stimulated STAT1/3 activation in A431 cells.
Tenev T; Böhmer SA; Kaufmann R; Frese S; Bittorf T; Beckers T; Böhmer FD
Eur J Cell Biol; 2000 Apr; 79(4):261-71. PubMed ID: 10826494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
